AChild - Austrian Children With Hearing Impairment - Longitudinal Database - Trial NCT04317456
Access comprehensive clinical trial information for NCT04317456 through Pure Global AI's free database. This phase not specified trial is sponsored by Johannes Kepler University of Linz and is currently Recruiting. The study focuses on Hearing Impaired Children. Target enrollment is 450 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Johannes Kepler University of Linz
Timeline & Enrollment
N/A
Sep 01, 2019
Aug 01, 2025
Primary Outcome
Vocabulary Expressive of the Child,Vocabulary Receptive of the Child,Grammar Expressive of the Child,Language Receptive of the Child,Language Receptive of the Child (ÖGS),Social Communication of the Child,Symbolic Behaviour of the Child,Psychosocial Development of the Child,Emotional and Behaviour Problems of the Child,Quality of Life of the Child,Family Stress,Parental Self-Efficacy,Non-Verbal Development
Summary
There is high variability in outcomes in children with hearing impairment. Existing
 literature focus mainly on subpopulations (children with hearing aids, children with CI) and
 is usually not epidemiological. Often children with additional needs (intellectual
 disability, visual impairment, autism spectrum disorder, complex syndromes) are excluded from
 the studies. This subgroup of children makes up around 1/3 of the population of children with
 hearing impairment.
 
 What factors contribute to the unexplained variance in language development in children with
 hearing loss? (including children with additional needs, multilingual) There is a lack of
 European epidemiological studies that evaluate the effects of Newborn Hearing Screening and
 early intervention.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04317456
Device Trial